Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Doubts Over China's First Alzheimer's Drug Resurface Amid Research Miscount Allegation
Speed Over Quality?
Jul 09 2020
•
By
Brian Yang
LEADING RESEARCHER QUESTIONS CHINA AD DRUG GV971 - 'IMPOSSIBLE WITHOUT FABRICATION' • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from China
More from Focus On Asia